4716df21c912ddeeb03c795a0b463a585cd90828
ANK2.md
| ... | ... | @@ -10,9 +10,7 @@ nocite: | |
| 10 | 10 | |
| 11 | 11 | ## Relevance tier by entity |
| 12 | 12 | |
| 13 | -|Entity|Tier|Description | |
|
| 14 | -|:------:|:----:|---------------------------------------| |
|
| 15 | -| |2 |relevance in MCL not firmly established[@zhangGenomicLandscapeMantle2014]| |
|
| 13 | +[[include:table1_ANK2.md]] |
|
| 16 | 14 | |
| 17 | 15 | ## Mutation incidence in large patient cohorts (GAMBL reanalysis) |
| 18 | 16 |
ANKLE2.md
| ... | ... | @@ -13,9 +13,7 @@ nocite: | |
| 13 | 13 | |
| 14 | 14 | ## Relevance tier by entity |
| 15 | 15 | |
| 16 | -|Entity|Tier|Description| |
|
| 17 | -|:------:|:----:|--------------------------------------| |
|
| 18 | -||2|relevance in DLBCL not firmly established[@pasqualucciAnalysisCodingGenome2011]| |
|
| 16 | +[[include:table1_ANKLE2.md]] |
|
| 19 | 17 | |
| 20 | 18 | |
| 21 | 19 |
ANKRD12.md
| ... | ... | @@ -14,9 +14,7 @@ Mutations in this gene were first described in DLBCL in 2021 by Hübschmann et a |
| 14 | 14 | |
| 15 | 15 | ## Relevance tier by entity |
| 16 | 16 | |
| 17 | -|Entity|Tier|Description | |
|
| 18 | -|:------:|:----:|-----------------------------------------| |
|
| 19 | -| |2 |relevance in DLBCL not firmly established[@hubschmannMutationalMechanismsShaping2021]| |
|
| 17 | +[[include:table1_ANKRD12.md]] |
|
| 20 | 18 | |
| 21 | 19 | ## Mutation incidence in large patient cohorts (GAMBL reanalysis) |
| 22 | 20 |
ANKRD17.md
| ... | ... | @@ -10,9 +10,7 @@ nocite: | |
| 10 | 10 | |
| 11 | 11 | ## Relevance tier by entity |
| 12 | 12 | |
| 13 | -|Entity|Tier|Description | |
|
| 14 | -|:------:|:----:|-----------------------------------------| |
|
| 15 | -| |2 |relevance in DLBCL not firmly established[@zhangGeneticHeterogeneityDiffuse2013]| |
|
| 13 | +[[include:table1_ANKRD17.md]] |
|
| 16 | 14 | |
| 17 | 15 | ## Mutation incidence in large patient cohorts (GAMBL reanalysis) |
| 18 | 16 |
ANKRD44.md
| ... | ... | @@ -13,9 +13,7 @@ nocite: | |
| 13 | 13 | |
| 14 | 14 | ## Relevance tier by entity |
| 15 | 15 | |
| 16 | -|Entity|Tier|Description| |
|
| 17 | -|:------:|:----:|--------------------------------------| |
|
| 18 | -||3|relevance in DLBCL not firmly established[@zhangGeneticHeterogeneityDiffuse2013]| |
|
| 16 | +[[include:table1_ANKRD44.md]] |
|
| 19 | 17 | |
| 20 | 18 | |
| 21 | 19 |
ANTXR1.md
| ... | ... | @@ -13,9 +13,7 @@ nocite: | |
| 13 | 13 | |
| 14 | 14 | ## Relevance tier by entity |
| 15 | 15 | |
| 16 | -|Entity|Tier|Description| |
|
| 17 | -|:------:|:----:|--------------------------------------| |
|
| 18 | -||3|relevance in DLBCL not firmly established[@zhangGeneticHeterogeneityDiffuse2013]| |
|
| 16 | +[[include:table1_ANTXR1.md]] |
|
| 19 | 17 | |
| 20 | 18 | |
| 21 | 19 |
AOC2.md
| ... | ... | @@ -13,9 +13,7 @@ nocite: | |
| 13 | 13 | |
| 14 | 14 | ## Relevance tier by entity |
| 15 | 15 | |
| 16 | -|Entity|Tier|Description| |
|
| 17 | -|:------:|:----:|--------------------------------------| |
|
| 18 | -||2|relevance in MZL not firmly established[@spinaGeneticsNodalMarginal2016]| |
|
| 16 | +[[include:table1_AOC2.md]] |
|
| 19 | 17 | |
| 20 | 18 | |
| 21 | 19 | ## Mutation incidence in large patient cohorts (GAMBL reanalysis) |
AP1G2.md
| ... | ... | @@ -13,9 +13,7 @@ nocite: | |
| 13 | 13 | |
| 14 | 14 | ## Relevance tier by entity |
| 15 | 15 | |
| 16 | -|Entity|Tier|Description| |
|
| 17 | -|:------:|:----:|--------------------------------------| |
|
| 18 | -||3|relevance in DLBCL not firmly established[@zhangGeneticHeterogeneityDiffuse2013]| |
|
| 16 | +[[include:table1_AP1G2.md]] |
|
| 19 | 17 | |
| 20 | 18 | |
| 21 | 19 |
APBB1.md
| ... | ... | @@ -13,9 +13,7 @@ nocite: | |
| 13 | 13 | |
| 14 | 14 | ## Relevance tier by entity |
| 15 | 15 | |
| 16 | -|Entity|Tier|Description| |
|
| 17 | -|:------:|:----:|--------------------------------------| |
|
| 18 | -||3|relevance in DLBCL not firmly established[@zhangGeneticHeterogeneityDiffuse2013]| |
|
| 16 | +[[include:table1_APBB1.md]] |
|
| 19 | 17 | |
| 20 | 18 | |
| 21 | 19 |
APC.md
| ... | ... | @@ -13,9 +13,7 @@ nocite: | |
| 13 | 13 | |
| 14 | 14 | ## Relevance tier by entity |
| 15 | 15 | |
| 16 | -|Entity|Tier|Description| |
|
| 17 | -|:------:|:----:|--------------------------------------| |
|
| 18 | -||3|relevance in DLBCL not firmly established[@zhangGeneticHeterogeneityDiffuse2013]| |
|
| 16 | +[[include:table1_APC.md]] |
|
| 19 | 17 | |
| 20 | 18 | |
| 21 | 19 |
APMAP.md
| ... | ... | @@ -13,9 +13,7 @@ nocite: | |
| 13 | 13 | |
| 14 | 14 | ## Relevance tier by entity |
| 15 | 15 | |
| 16 | -|Entity|Tier|Description| |
|
| 17 | -|:------:|:----:|--------------------------------------| |
|
| 18 | -||3|relevance in DLBCL not firmly established[@fanComprehensiveCharacterizationDriver2020]| |
|
| 16 | +[[include:table1_APMAP.md]] |
|
| 19 | 17 | |
| 20 | 18 | |
| 21 | 19 |